| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212240 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 29 Pages |
Abstract
G4 nadir during CRT for EC was associated with poor outcomes, suggesting a role of host immunity in disease control. This observation provides a rationale to prospectively test chemotherapeutic and radiation treatment strategies that may have a lower impact on host immunity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rajayogesh MD, Wen MD, PhD, Penny MD, Cai MD, Ritsuko MD, Daniel R. MD, James MD, James D. MD, Christopher H. MD, Charles C. MD, PhD, Steven H. MD, PhD,